Cancer Prevention Vaccines

Cancer vaccines—particularly those targeting breast cancer, melanoma, and colon cancer—have progressed quickly to clinical trials following promising results in preclinical mouse model studies. These vaccines are typically most effective when administered before exposure to the virus. There are two main types of cancer-related vaccines: preventive vaccines and therapeutic vaccines. Preventive vaccines, approved by the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA), are designed to protect against oncoviruses—viruses known to increase cancer risk, such as HPV and hepatitis B. In contrast, therapeutic vaccines are developed to stimulate the immune system to recognize and destroy existing cancer cells.

 

    Related Conference of Cancer Prevention Vaccines

    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    October 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    Zurich, Switzerland
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Cancer Prevention Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in